These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Why big lies matter: lessons from the Bezwoda affair. Sledge GW Medscape Womens Health; 2000 Jan; 5(1):4. PubMed ID: 10841629 [No Abstract] [Full Text] [Related]
3. After Bezwoda. Horton R Lancet; 2000 Mar; 355(9208):942-3. PubMed ID: 10768426 [No Abstract] [Full Text] [Related]
4. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed. Vogl DT; Stadtmauer EA Bone Marrow Transplant; 2006 Jun; 37(11):985-7. PubMed ID: 16708060 [No Abstract] [Full Text] [Related]
5. In the aftermath of scientific fraud. Eur J Cancer; 2000 May; 36(8):951-2. PubMed ID: 10885595 [No Abstract] [Full Text] [Related]
6. Re: "Bezwoda: evidence of fabrication in original article". Vickers A; Christos P J Clin Oncol; 2000 Nov; 18(22):3875. PubMed ID: 11078504 [No Abstract] [Full Text] [Related]
7. [High-dose chemotherapy with hematopoietic stem-cell support in breast cancer]. Viens P; Maraninchi D Bull Cancer; 2001 Sep; 88(9):835-41. PubMed ID: 11604355 [No Abstract] [Full Text] [Related]
8. Breast cancer researcher accused of serious scientific misconduct. Gottlieb S BMJ; 2000 Feb; 320(7232):398. PubMed ID: 10669430 [No Abstract] [Full Text] [Related]
9. High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study. Weiss RB; Rifkin RM; Stewart FM; Theriault RL; Williams LA; Herman AA; Beveridge RA Lancet; 2000 Mar; 355(9208):999-1003. PubMed ID: 10768448 [TBL] [Abstract][Full Text] [Related]
10. Cancer researcher in South Africa who falsified data is fired. Cauvin HE N Y Times Web; 2000 Mar; ():A16. PubMed ID: 11873790 [TBL] [Abstract][Full Text] [Related]
11. Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data. Antman KH J Clin Oncol; 1999 Nov; 17(11 Suppl):30-4. PubMed ID: 10630259 [No Abstract] [Full Text] [Related]
12. Alleged misconduct in breast cancer trial. Eur J Cancer; 2000 Mar; 36(5):552. PubMed ID: 10847690 [No Abstract] [Full Text] [Related]
14. Towards the integration of hematopoietic stem cells into therapy of breast cancer? Siena S Haematologica; 1999 Oct; 84(10):865-7. PubMed ID: 10509030 [No Abstract] [Full Text] [Related]
15. High-dose chemotherapy in breast cancer -- the perils of history uncontrolled. Miller KD; Sledge GW Medscape Womens Health; 2000; 5(3):E1. PubMed ID: 11109042 [TBL] [Abstract][Full Text] [Related]
16. Mishandling misconduct: the breast cancer trials scandal. Mittra I Natl Med J India; 1994; 7(6):255-7. PubMed ID: 7841873 [No Abstract] [Full Text] [Related]
17. No place for politics. Fee K Mod Healthc; 2000 May; 30(21):48, 50. PubMed ID: 11067549 [No Abstract] [Full Text] [Related]
19. Better prioritization may speed approval of adjuvant therapies in breast cancer. Tuma RS J Natl Cancer Inst; 2008 Jun; 100(12):842-4. PubMed ID: 18544735 [No Abstract] [Full Text] [Related]
20. Clinical results in 2001 show high dose therapy and hematopoietic progenitor cell transplantation as a therapeutic option for breast cancer. Pedrazzoli P; Siena S Haematologica; 2001 Sep; 86(9):900-7. PubMed ID: 11532617 [No Abstract] [Full Text] [Related] [Next] [New Search]